These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 23558684)
1. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43). Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684 [TBL] [Abstract][Full Text] [Related]
2. Conserved acidic amino acid residues in a second RNA recognition motif regulate assembly and function of TDP-43. Shodai A; Ido A; Fujiwara N; Ayaki T; Morimura T; Oono M; Uchida T; Takahashi R; Ito H; Urushitani M PLoS One; 2012; 7(12):e52776. PubMed ID: 23300771 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43). Prakash A; Kumar V; Meena NK; Hassan MI; Lynn AM J Biomol Struct Dyn; 2019 Jan; 37(1):178-194. PubMed ID: 29279008 [TBL] [Abstract][Full Text] [Related]
4. Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state. Mackness BC; Tran MT; McClain SP; Matthews CR; Zitzewitz JA J Biol Chem; 2014 Mar; 289(12):8264-76. PubMed ID: 24497641 [TBL] [Abstract][Full Text] [Related]
5. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals. Tamaki Y; Shodai A; Morimura T; Hikiami R; Minamiyama S; Ayaki T; Tooyama I; Furukawa Y; Takahashi R; Urushitani M Sci Rep; 2018 Apr; 8(1):6030. PubMed ID: 29662239 [TBL] [Abstract][Full Text] [Related]
6. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation. French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544 [TBL] [Abstract][Full Text] [Related]
7. RNP2 of RNA recognition motif 1 plays a central role in the aberrant modification of TDP-43. Takagi S; Iguchi Y; Katsuno M; Ishigaki S; Ikenaka K; Fujioka Y; Honda D; Niwa J; Tanaka F; Watanabe H; Adachi H; Sobue G PLoS One; 2013; 8(6):e66966. PubMed ID: 23840565 [TBL] [Abstract][Full Text] [Related]
8. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. Johnson BS; Snead D; Lee JJ; McCaffery JM; Shorter J; Gitler AD J Biol Chem; 2009 Jul; 284(30):20329-39. PubMed ID: 19465477 [TBL] [Abstract][Full Text] [Related]
9. Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells. Yamanaka Y; Miyagi T; Harada Y; Kuroda M; Kanekura K Lab Invest; 2021 Oct; 101(10):1331-1340. PubMed ID: 34131277 [TBL] [Abstract][Full Text] [Related]
10. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080 [TBL] [Abstract][Full Text] [Related]
11. Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1. Pokrishevsky E; DuVal MG; McAlary L; Louadi S; Pozzi S; Roman A; Plotkin SS; Dijkstra A; Julien JP; Allison WT; Cashman NR J Biol Chem; 2024 May; 300(5):107207. PubMed ID: 38522514 [TBL] [Abstract][Full Text] [Related]
12. A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. Furukawa Y; Kaneko K; Watanabe S; Yamanaka K; Nukina N J Biol Chem; 2011 May; 286(21):18664-72. PubMed ID: 21454603 [TBL] [Abstract][Full Text] [Related]
13. An Cascella R; Banchelli M; Abolghasem Ghadami S; Ami D; Gagliani MC; Bigi A; Staderini T; Tampellini D; Cortese K; Cecchi C; Natalello A; Adibi H; Matteini P; Chiti F Ann Med; 2023 Dec; 55(1):72-88. PubMed ID: 36495262 [No Abstract] [Full Text] [Related]
14. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis. Kim HC; Zhang Y; King PH; Lu L J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420 [TBL] [Abstract][Full Text] [Related]
16. ALS-causing cleavages of TDP-43 abolish its RRM2 structure and unlock CTD for enhanced aggregation and toxicity. Wei Y; Lim L; Wang L; Song J Biochem Biophys Res Commun; 2017 Apr; 485(4):826-831. PubMed ID: 28257838 [TBL] [Abstract][Full Text] [Related]
17. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy. Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140 [TBL] [Abstract][Full Text] [Related]
18. Small Molecule Targeting TDP-43's RNA Recognition Motifs Reduces Locomotor Defects in a François-Moutal L; Felemban R; Scott DD; Sayegh MR; Miranda VG; Perez-Miller S; Khanna R; Gokhale V; Zarnescu DC; Khanna M ACS Chem Biol; 2019 Sep; 14(9):2006-2013. PubMed ID: 31241884 [TBL] [Abstract][Full Text] [Related]
19. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients. Yamashita T; Kwak S Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598 [TBL] [Abstract][Full Text] [Related]
20. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death. Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]